Giredestrant (GDC-9545) is a potential best-in-class selective estrogen receptor inhibitor (SERD). Giredestrant can competitively bind with Estradiol in the ER ligand binding domain and induce conformational changes. Giredestrant has antitumor activity
Molecular Weight:
522.55
Purity:
>99.0%
CAS Number:
[1953133-47-5]
Formula:
C27H31F5N4O
Target:
Estrogen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted